HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up

201295 citationsJournal Article

Authors

Microtransplantation as a postremission therapy may improve outcomes and avoid GVHD in patients with AML-CR1.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 30, Issue 33, pp. 4084-4090

Field-Weighted Citation Impact: 4.11